While working to understand not only his own rare disease but also how the broader healthcare industry develops treatments for rare diseases as a whole, Onno Faber uncovered the building blocks of his new company.
Infectious disease and public policy experts investigated the global pandemic response, cataloged its many failures and assembled recommendations for future. But sadly their words will probably fall flat.
Global warming has, in certain instances, amped up some of the world’s most deadly diseases.
In his latest book, clinical geneticist and biotech entrepreneur Dr. Phil Reilly chronicles centuries of medical progress that have contributed to recent breakthroughs in rare disease medicines, diagnostics, and clinical care. He says we're just...